• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home Health A to Z

Patient Basics: Retinitis Pigmentosa

byHarvard Health
November 30, 2014
in Health A to Z
Reading Time: 3 mins read
Share on FacebookShare on Twitter

Originally published by Harvard Health.

What Is It?

Retinitis pigmentosa (RP) is an eye disease. It leads to gradual loss of vision and, sometimes, blindness.

RP occurs when the light-sensing cells in the eye break down. These cells, called rods and cones, are located in the retina. This is the back portion of the eye that sends visual information to the brain.

The first signs of RP usually can be detected by age 10. The first symptoms usually show up in adolescence. The total amount of vision loss and how quickly the disease worsens vary from person to person.

No one knows exactly what causes RP. It is believed to be an inherited disorder. However, in some cases, the disease occurs in people who do not have a family history of the disease.

The disorder also can show up as part of other syndromes. These include Bassen-Kornzweig disease or Kearns-Sayre syndrome.

RELATED REPORTS

Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosa

Symptoms

The first symptom of RP is usually diminished night vision. It becomes more difficult to see in dimly lit or dark places.

People with RP also slowly lose peripheral (side) vision and visual sharpness.

Over time, the disorder leads to tunnel vision. The outer edges of vision are dark, leaving a shrinking circle of vision in the center.

Eventually, people with RP can go blind. But most people with this disorder retain some vision, even in old age.

Diagnosis

You will be diagnosed by an ophthalmologist. This is a doctor who specializes in eye disorders.

The ophthalmologist may do a number of diagnostic tests. The physician will use an instrument called an ophthalmoscope to look at the inside of the eye through the pupil. In a normal eye, the physician will see an orange or orange-red area called the fundus. In a person with RP, the orange area will have brown or black blotches.

Visual-field tests can be done. These measure a person’s peripheral vision.

To confirm a diagnosis of retinitis pigmentosa, an ophthalmologist may do an electroretinogram (ERG). During this test, lights of different colors and intensities are flashed into your eye as you peer into a large reflective globe. A contact lens that contains an electrode is placed on your eye. A wire transmits a record of your eye’s retina activity. The ERG creates a paper tracing of electrical impulses. People with RP have lower-than-normal electrical activity in their retina.

Expected Duration

Most often RP is an inherited disorder.

Doctors can see the first signs of RP as early as age 10. Symptoms typically begin in adolescence. They slowly worsen over time.

The severity of the disease varies from person to person. However, the disorder and visual loss last a lifetime.

Prevention

Because RP is a genetic disorder, there is no way to prevent it. There is no proven way to prevent or delay the associated vision loss.

Treatment

There is no known treatment for RP.

Some research suggests that high doses of vitamin A (15,000 IU/day) may slow degeneration a little in some people. However, the evidence for this is not strong. In addition, there are potential toxic effects of taking too much vitamin A.

If you have RP and want to try vitamin A therapy, talk with your physician first. Ask about the safety and potential value of this treatment.

When To Call a Professional

See your health care professional if you notice any change in your vision. This includes a decreased ability to see at night or loss of peripheral vision.

Prognosis

RP cannot be cured. The visual loss is both progressive and permanent.

The amount and speed of degeneration varies by individual. Therefore, the extent of vision loss cannot be predicted.

Many patients afflicted with this condition lead fairly normal lives.

Additional Info

American Academy of Ophthalmology
P.O. Box 7424
San Francisco, CA 94120-7424
Phone: 415-561-8500
Fax: 415-561-8533
http://www.aao.org/news/eyenet/

National Eye Institute
2020 Vision Place
Bethesda, MD 20892-3655
Phone: 301-496-5248
http://www.nei.nih.gov/

 

 

 

Tags: Retinitis Pigmentosa
Previous Post

Patient Basics: Retinal Artery Occlusion

Next Post

Patient Basics: Retinoblastoma

RelatedReports

Adalimumab aids in control of noninfectious uveitis
Pharma

Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosa

May 19, 2024
Next Post

Patient Basics: Raynaud's Phenomenon

Patient Basics: Reactive Arthritis

Patient Basics: Respiratory Syncytial Virus

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.